JPS57197271A - Prostaglandin, manufacture and prostaglandin drug - Google Patents

Prostaglandin, manufacture and prostaglandin drug

Info

Publication number
JPS57197271A
JPS57197271A JP57060855A JP6085582A JPS57197271A JP S57197271 A JPS57197271 A JP S57197271A JP 57060855 A JP57060855 A JP 57060855A JP 6085582 A JP6085582 A JP 6085582A JP S57197271 A JPS57197271 A JP S57197271A
Authority
JP
Japan
Prior art keywords
prostaglandin
manufacture
drug
prostaglandin drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57060855A
Other languages
Japanese (ja)
Inventor
Fuoaburiyutsugen Herumuuto
Erugaa Buarutaa
Taun Maikeruuharorudo
Shiringaa Etsukeharuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS57197271A publication Critical patent/JPS57197271A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP57060855A 1981-04-13 1982-04-12 Prostaglandin, manufacture and prostaglandin drug Pending JPS57197271A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813115997 DE3115997A1 (en) 1981-04-13 1981-04-13 Novel prostaglandins and prostacyclins, process for their preparation and their use as medicaments

Publications (1)

Publication Number Publication Date
JPS57197271A true JPS57197271A (en) 1982-12-03

Family

ID=6130600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57060855A Pending JPS57197271A (en) 1981-04-13 1982-04-12 Prostaglandin, manufacture and prostaglandin drug

Country Status (3)

Country Link
JP (1) JPS57197271A (en)
DE (1) DE3115997A1 (en)
ZA (1) ZA822491B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03130227A (en) * 1989-07-27 1991-06-04 Ueno Seiyaku Oyo Kenkyusho:Kk Potassium, suppressing and secreting agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03130227A (en) * 1989-07-27 1991-06-04 Ueno Seiyaku Oyo Kenkyusho:Kk Potassium, suppressing and secreting agent

Also Published As

Publication number Publication date
ZA822491B (en) 1983-02-23
DE3115997A1 (en) 1982-11-04

Similar Documents

Publication Publication Date Title
PH25637A (en) Dipyridamole-containing pharmaceutical form
JPS57140732A (en) Ethanol continuous manufacture
DE3262455D1 (en) Diphenoxypropane derivatives, their production and use
JPS5716868A (en) 1-hydroxyethyl-azole derivative,manufacture and use
JPS5753473A (en) Novel n-aryl-2-oxazolidinones, manufacture and drug containing them
JPS5718624A (en) Drug and manufacture
JPS57120586A (en) Dibenzazepine derivative, manufacture and use
JPS57165367A (en) Manufacture of 2,3-dichloro-5-trichloromethylpyridine
DE3273986D1 (en) Homobrassinolide, and its production and use
JPS56164191A (en) Theophyllinylmethyldioxolane derivative, its manufacture and medicine
AU563268B2 (en) Catalyst manufacture
JPS57159784A (en) Pyridine compound, manufacture and use
DE3260505D1 (en) Alicyclic compounds, their production and use
IL66305A0 (en) Preparation of 1-substituted-3,4-diphenyl-5-methyl-pyrazoles
JPS57165307A (en) Vermicides, manufacture and use
JPS57197296A (en) Novel aminoacridine-glycoside derivative, manufacture and medicine
JPS57197271A (en) Prostaglandin, manufacture and prostaglandin drug
CS914282A2 (en) Hydraulicky valec, zejmena dulni vzpera s kombinovanou funkci
DE3267439D1 (en) Trifluoromethanesulfonanilides, and their production and use
JPS57193492A (en) Manufacture of o,s-dialkylphosphoroamidothioates
JPS57188593A (en) Novel dioxazabicyclo derivative, manufacture and drug
JPS57169442A (en) Substituted alpha-halogenopropionic acid, derivatives thereof and manufacture
JPS57159797A (en) Antiviral, manufacture and medicinal composition
JPS57181076A (en) Spiro-1-isobenzofuranic and spiro-1- isobenzothiophenic derivatives, manufacture and drug containing them
JPS57193452A (en) Manufacture of 4-thioazetidinone compound, 4-nitrosothioazetidinone and manufacture